Interim PET provides limited prognostic value for diffuse large B-cell lymphomaJuly 7, 2015Indolent Lymphoma
ABVD and Stanford V similar for bulky mediastinal Hodgkin’s lymphomaApril 20, 2015Aggressive Lymphomas
Ibrutinib highly active against refractory Waldenstrom’s macroglobulinemiaApril 8, 2015Indolent Lymphoma
Autologous stem-cell transplant boosts survival in sequential transformed indolent lymphomaDecember 11, 2014Aggressive Lymphomas
Brentuximab changes landscape for post-transplant Hodgkin’s lymphoma patientsDecember 7, 2014Aggressive Lymphomas
PD-1 checkpoint inhibitors show mettle against relapsed Hodgkin’s lymphomaDecember 7, 2014Aggressive Lymphomas
Repeat biopsy and long-term surveillance key for rare Hodgkin’s lymphoma subtype June 20, 2014Aggressive Lymphomas
